ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma

Published:2022-04-04 Issue:6 Volume:36 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:Clinical Laboratory Analysis

Author:

ling Jie¹,Peng Ning¹,luo Lifei²³^ORCID

Affiliation:

1. Department of Clinical Laboratory Taizhou First People’s Hospital Huangyan Hospital of Wenzhou Medical University Taizhou China

2. Department of Clinical Laboratory Taizhou Hospital of Zhengjiang Province affiliated of Wenzhou Medical University Linhai China

3. Department of Clinical Laboratory Taizhou Enze Medical Center (Group) Enze Hospital Taizhou China

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.24362

Reference33 articles.

1. Breast cancer

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

4. Breast Cancer, Version 3.2018

5. Immune Infiltration in Invasive Lobular Breast Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP